Previous close | 42.66 |
Open | 42.99 |
Bid | 42.33 x 100 |
Ask | 42.49 x 200 |
Day's range | 42.03 - 43.13 |
52-week range | 36.06 - 67.66 |
Volume | |
Avg. volume | 417,706 |
Market cap | 2.075B |
Beta (5Y monthly) | 0.84 |
PE ratio (TTM) | 16.33 |
EPS (TTM) | 2.60 |
Earnings date | 08 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 63.25 |
Amphastar Pharmaceuticals (NASDAQ:AMPH) has had a rough three months with its share price down 19%. But if you pay...
Taysha Gene Therapies (TSHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.